Recently, Noorani et al. explored the role of EGFR mutants in IDH1 wild-type gliomas through whole-exome sequencing, transcriptomics and transposon mutagenesis forward genetic screening, and found new putative tumor suppressors [8]. This evidence concerns the gene IDH1 and glioma.